Nestlé is using AI to build a new line of food products for weight loss drug users

The company says AI tools are helping it analyze clinical research and identify nutrients to address side effects like muscle loss

Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and nutritional science to develop products aimed at millions of consumers taking medicines such as Ozempic and Wegovy.

Nestle executive says rapid rise of weight-loss drugs creates opportunity

Some men say they feel ashamed of needing to use weight-loss injections as it seems like "cheating".

The firm's calculations show that workers on median salaries stand to lose approximately £163,000

The government has appointed 2005-batch IPS officer Avinash Mohanty, who was serving as Director General of the DCA, as Commissioner of TG SAFE, in addition to his existing duties.

Users need discretionary income of nearly £100,000 a year to make savings on their grocery spend after paying £1,200 for GLP-1s, analysis finds The high cost of weight-loss medication is a “regressive tax on being thin” because the outlay outweighs any saving on food costs for all but the highest earners. Someone needs

Weight loss drugs are effectively the blockbuster drugs of the modern era.

Phoebe Gates: Does her biggest business controversy show the weight of being Bill Gates’ daughter?  MARCA

New York Post Composite Starting on a GLP-1 medication can seem intimidating — not to mention expensive. But it doesn’t have to be. Arbor offers two of the most popular, doctor-prescribed GLP-1 weight loss treatments at locked-in prices, even if your dose changes. Plans start at $99/month, a stark difference from the $